Shad R, Zakka C, Kaur D, Mathur M, Fong R, Cho J, Filice RW, Mongan J, Kallianos K, Khandwala N, Eng D, Leipzig M, Witschey WR, de Feria A, Ferrari VA, Ashley EA, Acker MA, Langlotz C, Hiesinger W. A Generalizable Deep Learning System for Cardiac MRI
, Nature Biomedical Engineering: 2026
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, DE Feria A, Marzolf A, Owens AT. Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy , Journal of Cardiac Failure Intersections: 2026
Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, DE Feria A, Hornsby N, Marzolf A, Owens AT. Association Between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , Journal of Cardiac Failure: 2026
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT. Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , JACC Heart Failure: 2025
Reza N, Dubey A, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Marzolf A, Hornsby N, de Feria A, Carattini T, Schuler P, Owens AT. Long Term Real World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks , Journal of Clinical Medicine: 2025
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT. Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , JACC Heart Failure: 2025
Thomas A Boyle, Nosheen Reza, Matthew Hyman, Gregory Supple, Vincent Y See, Amy Marzolf, Nicole Hornsby, Alejandro de Feria, Teresa Wang, Kenneth B Margulies, Anjali Tiku Owens, David S Frankel Atrial Fibrillation in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Real-World Incidence, Management, and Outcomes , Research Letter: JACC Clinical Electrophysiology: 2025
Melissa A Austin, Alejandro de Feria, Nosheen Reza, Anjali Owens Riding the Waves of Novel Therapies in Hypertrophic Cardiomyopathy , JACC Case Reports: 2024
Niccolò Maurizi 1 2, Panagiotis Antiochos 2, Anjali Owens 3, Neal Lakdwala 4, Sara Saberi 5, Mark W Russell 6, Carlo Fumagalli 1 7, Ioannis Skalidis 2, Kimberly Y Lin 8, Ashwin S Nathan 3, Alejandro De Feria Alsina 3, Nosheen Reza 3, John C Stendahl 9, Dominic Abrams 10, Christopher Semsarian 11 12 13, Brian Clagget 14, Rachel Lampert 8, Matthew Wheeler 15, Victoria N Parikh 15, Euan Ashley 15, Michelle Michels 16, Joseph Rossano 8, Thomas D Ryan 17, Jodie Ingles 18, James Ware 19, Carolyn Y Ho 4, Adam S Helms 5, Sharlene M Day # 3, Iacopo Olivotto Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry. , Circulation: 2024
Nosheen Reza, Anandkumar Dubey, Thomas Carattini, Amy Marzolf, Nicole Hornsby, Alejandro de Feria, Nadim Mahmud, Patricia Schuler, Anjali Tiku Owens Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , JACC Heart Failure, 12(6): 2024,1123-1125
